GENERAL BIOLOGICALS CORPORATION General Biologicals Corporation Stock
Equities
4117
TW0004117007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.5 TWD | 0.00% |
|
+1.90% | -20.37% |
| Sales 2021 | 552M 16.94M | Sales 2022 | 370M 11.37M | Capitalization | 1.61B 49.41M |
|---|---|---|---|---|---|
| Net income 2021 | 44M 1.35M | Net income 2022 | -53M -1.63M | EV / Sales 2021 | 3.92 x |
| Net Debt 2021 | 80.66M 2.48M | Net Debt 2022 | 118M 3.62M | EV / Sales 2022 | 4.66 x |
| P/E ratio 2021 |
47.2
x | P/E ratio 2022 |
-30.2
x | Employees | 81 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| 1 week | +1.90% | ||
| Current month | -1.83% | ||
| 1 month | -3.59% | ||
| 3 months | -10.79% | ||
| 6 months | -6.93% | ||
| Current year | -20.37% |
1 week
20.40
21.70
1 month
20.4022.50
Current year
20.4027.95
1 year
20.4030.20
3 years
18.50105.00
5 years
5.71278.00
10 years
5.71278.00
| Managers | Title | Age | Since |
|---|---|---|---|
Meng Te Lin
CEO | Chief Executive Officer | - | 13-07-14 |
En Jung Tsao
DFI | Director of Finance/CFO | - | - |
Meng Hui Lin
PRN | Corporate Officer/Principal | - | 13-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming-Chih Hsuan
BRD | Director/Board Member | 70 | 10-06-23 |
Tsung Ching Lin
CHM | Chairman | - | 89-05-24 |
Pi Hua Chen
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 21.5 | 0.00% | 32,808 |
| 24-04-24 | 21.5 | +3.37% | 65,742 |
| 24-04-23 | 20.8 | +0.24% | 22,556 |
| 24-04-22 | 20.75 | +0.73% | 46,613 |
| 24-04-19 | 20.6 | -2.37% | 69,308 |
End-of-day quote Taipei Exchange, April 24, 2024
More quotes
GENERAL BIOLOGICALS CORP. is a Taiwan-based company principally engaged in the design, development, manufacture, sales and import and export trading of diagnostic kits and auxiliary equipment, as well as the provision of medical technology services. The Company's main products include detection reagents, biological protein new drug, P113, and medical supplies. The Company distributes its products in domestic market and to overseas markets.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.37% | 39.45M | |
| -0.60% | 12.59B | |
| -12.53% | 7.42B | |
| +1.78% | 5.35B | |
| -1.37% | 4.51B | |
| +5.16% | 4.47B | |
| -51.93% | 3.21B | |
| +11.34% | 2.71B | |
| -18.49% | 1.96B | |
| -11.07% | 1.73B |
- Stock Market
- Equities
- 4117 Stock
